Literature DB >> 8423095

Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice.

S J Green1, C A Nacy, R D Schreiber, D L Granger, R M Crawford, M S Meltzer, A H Fortier.   

Abstract

Peritoneal cells from Mycobacterium bovis BCG-infected C3H/HeN mice produced nitrite (NO2-, an oxidative end product of nitric oxide [NO] synthesis) and inhibited the growth of Francisella tularensis, a facultative intracellular bacterium. Both NO2- production and inhibition of bacterial growth were suppressed by NG-monomethyl-L-arginine, a substrate inhibitor of nitrogen oxidation of L-arginine, and monoclonal antibodies (MAbs) to gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). Intraperitoneal injection of mice with BCG increased urinary nitrate (NO3-) excretion coincident with development of activated macrophages capable of secreting nitrogen oxides and inhibiting F. tularensis growth in vitro. Eight days after BCG inoculation, mice survived a normally lethal intraperitoneal challenge with F. tularensis. Treatment of these BCG-infected mice with MAbs to IFN-gamma or TNF-alpha at the time of BCG inoculation reduced urinary NO3- levels to those found in normal uninfected mice for up to 14 days. The same anticytokine antibody treatment abolished BCG-mediated protection against F. tularensis: mice died within 4 to 6 days. Intraperitoneal administration of anti-IFN-gamma or anti-TNF-alpha antibody 8 days after BCG infection also reduced urinary NO3- and abolished protection against F. tularensis. Isotype control (immunoglobulin G) or anti-interleukin 4 MAbs had little effect on these parameters at any time of treatment. IFN-gamma and TNF-alpha were clearly involved in the regulation of macrophage activation by BCG in vivo. Protection against F. tularensis challenge by BCG depended upon the physiological generation of reactive nitrogen oxides induced by these cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423095      PMCID: PMC302781          DOI: 10.1128/iai.61.2.689-698.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

1.  Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.

Authors:  S J Green; M S Meltzer; J B Hibbs; C A Nacy
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

2.  Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway.

Authors:  J E Albina; C D Mills; W L Henry; M D Caldwell
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

3.  L-arginine is a precursor for nitrate biosynthesis in humans.

Authors:  C D Leaf; J S Wishnok; S R Tannenbaum
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

4.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections.

Authors:  A Nakane; T Minagawa; M Kohanawa; Y Chen; H Sato; M Moriyama; N Tsuruoka
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Evidence that tumor necrosis factor has an important role in antibacterial resistance.

Authors:  E A Havell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

7.  EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.

Authors:  J R Lancaster; J B Hibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins.

Authors:  C Pellat; Y Henry; J C Drapier
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

9.  Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.

Authors:  S L James; J Glaven
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

10.  Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells.

Authors:  R D Curran; T R Billiar; D J Stuehr; K Hofmann; R L Simmons
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  36 in total

1.  Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.

Authors:  Giang H Pham; Bibiana V Iglesias; Edmund J Gosselin
Journal:  Vaccine       Date:  2014-07-26       Impact factor: 3.641

2.  Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Authors:  Leah E Cole; Barbara J Mann; Kari Ann Shirey; Katharina Richard; Yang Yang; Patricia J Gearhart; Kirsty L Chesko; Rose M Viscardi; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2011-07-12       Impact factor: 4.962

Review 3.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

4.  Protective role of nitric oxide in Staphylococcus aureus infection in mice.

Authors:  S Sasaki; T Miura; S Nishikawa; K Yamada; M Hirasue; A Nakane
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Cellular immune responses to 35 kDa recombinant antigen of Mycobacterium avium paratuberculosis.

Authors:  S H Basagoudanavar; P P Goswami; V Tiwari
Journal:  Vet Res Commun       Date:  2006-05       Impact factor: 2.459

6.  Nitric oxide produced during murine listeriosis is protective.

Authors:  K S Boockvar; D L Granger; R M Poston; M Maybodi; M K Washington; J B Hibbs; R L Kurlander
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease.

Authors:  H M Feng; V L Popov; D H Walker
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.

Authors:  Ryan M Troyer; Katie L Propst; Jeff Fairman; Catherine M Bosio; Steven W Dow
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

9.  Interferon-gamma and tumor necrosis factor-alpha exert their antirickettsial effect via induction of synthesis of nitric oxide.

Authors:  H M Feng; D H Walker
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Authors:  Jennifer L Szczytkowski; Christina Lebonville; Lee Hutson; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2013-01-26       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.